PBI-05204

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2016
02420092016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
We previously reported neuroprotective activity of the botanical anti-cancer drug candidate PBI-05204, a supercritical CO2… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
Dear Sir: A recent letter to the Editor submitted by Dr. Miguel LopezLazaro and his colleagues provided thoughtful commentary on… (More)
Is this relevant?
2014
2014
Background PBI-05204, a Nerium oleander extract (NOE) containing the cardiac glycoside oleandrin, inhibits the α-3 subunit of Na… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2014
2014
Introduction Oleandrin, a cardiac glycoside, exerts strong anti-proliferative activity against various human malignancies in in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Dear Sir: We read with great interest the article “PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits growth of… (More)
Is this relevant?
2014
2014
We have previously shown that the botanical drug candidate PBI-05204, a supercritical CO2 extract of Nerium oleander, provides… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2011
2011
3023 Background: PBI-05204 (Oleandrin), a cardiac glycoside, inhibits the α-3 subunit Na-K ATPase pump. Relative expression of… (More)
Is this relevant?
2011
2011
The principal active constituent of the botanical drug candidate PBI-05204, a supercritical CO(2) extract of Nerium oleander, is… (More)
Is this relevant?
Review
2010
Review
2010
IMPORTANCE OF THE FIELD The evolution of targeted therapies is dependent upon identification of cellular moieties that can be… (More)
Is this relevant?
2009
2009
3537 Background: PBI-05204 contains oleandrin, a cardiac glycoside, which inhibits the α-3 subunit Na-K ATPase pump. Over… (More)
Is this relevant?